GlassScriptPhysician profile
Keith L Perkins
NPI 1225253883
$865.34
in general payments reported to CMS, 2019-2025
16 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.12 · 2020: $82.87 · 2021: $68.27 · 2022: $125 · 2023: $162 · 2024: $154 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $170.01 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $148.25 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $125.60 | 2025 | Caplyta |
| Novo Nordisk INC | $114.13 | 2023-2025 | Wegovy |
| Lilly USA, LLC | $99.19 | 2020-2024 | Jardiance, Emgality |
| Supernus Pharmaceuticals, INC. | $32.06 | 2022-2025 | Qelbree |
| Seqirus USA INC | $27.04 | 2022-2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Alexion Pharmaceuticals, INC. | $20.34 | 2020 | |
| Janssen Pharmaceuticals, INC | $19.83 | 2022 | |
| Ironshore Pharmaceuticals INC. | $19.39 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.43 | 2024 | Evkeeza |
| Cranial Technologies, INC | $16.32 | 2025 | Doc Band |
| Bayer Healthcare Pharmaceuticals INC. | $15.70 | 2021 | |
| Amgen INC. | $14.93 | 2020 | |
| Merck Sharp & Dohme LLC | $13.12 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.